Menu

CME Corner

Active Programs

Managing Type 2 Diabetes: The Role of Insulin

Type 2 diabetes (T2D) is a chronic, highly prevalent disease. Despite the availability of many treatment options, including new insulin formulations that have the potential to simplify treatment regimens, improve treatment adherence, and provide clinical benefit, patients often have poor glycemic control. This activity will examine the role of insulin therapy in the management of T2D. ...

  • Online Presentation Online Presentation
  • ACCME
  • ACPE

The Pharmacist's Role in Advanced or Metastatic Breast Cancer

Cyclin-dependent kinase (CDK) 4/6 inhibition significantly prolongs progression-free survival (PFS) in patients with metastatic breast cancer (mBRCA) whose disease progresses on endocrine therapies. This activity will examine emerging evidence and best practices supporting the use of CDK4/6 inhibitors. This activity was originally presented as a webcast series on the following 4 dates: February ...

  • Online Presentation
  • ACPE

Expired Programs

Best Practices in the Use of Incretin-based Therapies in the Management of Type 2 Diabetes (AANP Program ID 16032139)

This activity will address glycemic variability and cardiovascular considerations in patients with T2DM and examine therapeutic management, with a particular focus on the optimal use of GLP-1 receptor agonists and DPP-4 inhibitors. *Learners will be redirected to the AANP website. ...

  • Online Presentation Online Presentation
  • AANP

Contemporary Management of Type 2 Diabetes

The management of type 2 diabetes (T2D) remains a clinical challenge as patients continue to struggle with achieving therapeutic goals. While there are many treatment options for T2D, there is relatively limited guidance on selection of second- and third-line treatments. This activity will review the most recent T2D treatment guidelines (including strategies for patient communication), and address ...

  • Online Presentation Online Presentation
  • ACCME

Dialogue with the Experts: Diagnosing, Assessing, and Managing Inflammatory Rheumatic Diseases

Inflammatory rheumatic diseases, including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS), have a significant negative impact on patients’ physical functioning and quality of life. This activity will examine early recognition and guideline-driven treatment for these conditions. ...

  • Video Roundtable Video Roundtable
  • ACCME

Dialogue with the Experts: Strategies for Improving Interstitial Lung Disease Diagnosis and Treatment

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are often mischaracterized and a correct diagnosis is very often delayed. This activity will examine recent advances in ILD diagnosis and treatment. ...

  • Video Roundtable Video Roundtable
  • ACCME

Early Collaboration in the Treatment of PsA: Examining the Crucial Coalition Between Dermatology and Rheumatology in Psoriatic Arthritis Treatment

Psoriatic arthritis (PsA) is a serious, inflammatory arthritis associated with psoriasis and multiple comorbidities that often goes undiagnosed and untreated. This activity will examine strategies for early recognition and referral, as well as specialty collaboration in the treatment of PsA. ...

  • i-Newsletter i-Newsletter
  • ACCME

Effective Strategies for Improving Process of Care Measures for Patients with IBD: Key Findings from a Community-Based QI Pilot

This activity will examine key findings from a quality improvement pilot designed to learn how IBD nurses in the community can proactively improve the care of patients with IBD. ...

  • Video Roundtable Video Roundtable
  • ANCC

Evolving Paradigms for Insulin Therapy of Type 2 Diabetes
Case Challenges in the Use of Insulin in T2DM (Activity 2 of 3)

This activity uses interactive case scenarios to examine challenges in the management of T2DM. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Evolving Paradigms for Insulin Therapy of Type 2 Diabetes
Management of T2DM: The Role of Insulin (Activity 1 of 3)

This activity examines challenges encountered in the management of T2DM and the many therapeutic options available to clinicians. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Evolving Paradigms for Insulin Therapy of Type 2 Diabetes
Team-Based Care for Patients with Type 2 Diabetes (Activity 3 of 3)

This activity employs a multidisciplinary panel to examine the various clinical roles in the management of T2DM. ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

Identifying and Managing Patients with IBD at Risk for Progressive Disease

Treatment strategies for IBD vary depending on disease type, severity, and patient risk profile. This activity will examine severity and risk assessment, guideline recommended treatment, and patient communication strategies. ...

  • Online Presentation Online Presentation
  • ACCME

Improving Outcomes in Patients with Heart Failure: Closing the Gaps

In the United States, heart failure (HF) affects about 5.7 million adults, accounts for >1 million hospitalizations annually, and is the leading cause of hospitalization for adults >65 years of age. Despite diagnostic and therapeutic advances in the last several decades and improved survival rates, roughly 50% of people with HF die within 5 years of diagnosis. Rates of cardiovascular death or HF-r ...

  • Online Presentation Online Presentation
  • ACCME

Improving the Management of Depression in Primary Care: Insights into Diagnosis and Treatment (Program ID 16052200)

Major depressive disorder (MDD) is one of the most common mental disorders diagnosed in the United States, with an estimated 16% of US adults experiencing MDD at some point during their lifetimes. According to the American Medical Association, chronic depression is often untreated and, on average, patients with depression receive the recommended quality of care only 58% of the time. The goal of th ...

  • Online Presentation Online Presentation
  • AANP

Individualized Management of Pediatric Allergic Asthma

An evolving understanding of pediatric allergic asthma’s complex immunopathology is contributing to new treatment paradigms. This activity will examine the impact of asthma phenotypes and endotypes on treatment selection. ...

  • Online Presentation Online Presentation
  • ACCME

Metastatic Colorectal Cancer: Applying Evidence-based Recommendations for Evaluation and Management

Colorectal cancer is the third most common cancer in men and women. Current evidence-based guidelines recommend that all metastatic colorectal tumors be tested for RAS mutations (both KRAS and NRAS) and BRAF mutations, as the presence of such mutations has implications for treatment. Clinical practice is variable, however, and many patients do not receive guideline-based care. This activity will e ...

  • Online Presentation Online Presentation
  • ACCME
  • ANCC

Psoriasis and Psoriatic Arthritis: Strategies for Targeted Care and Multidisciplinary Management

What percentage of patients with psoriasis will eventually develop PsA? What therapies are FDA approved for both skin and joint symptoms? Psoriatic disease can have a substantial negative impact on patients’ quality of life. The treatments for psoriasis and PsA can overlap, although additional measures should be taken in patients with PsA to slow progression of joint damage, manage pain, and ...

  • Online Presentation Online Presentation
  • ACCME

Psoriatic Arthritis: Understanding the Patient Experience to Improve Patient Satisfaction and Outcomes

The validated tools to assess PsA severity often do not capture what patients consider to be most important/challenging about their disease. To effectively engage patients when developing treatment plans, clinicians need information about the patients’ individual experiences with, perceptions of, and beliefs about PsA. In this “Rate the Quality” activity, you will meet three patients and rate the ...

  • Mobile + Online on RealCME Mobile + Online on RealCME
  • ACCME

The Changing Landscape of Interstitial Lung Disease

Many patients with interstitial lung disease (ILD) do not receive a timely and accurate diagnosis prior to considerable disease progression. Management guidelines are vague and treatment options have been limited, leading to negative health outcomes and decreased quality of life. Advances in diagnostic strategies, recently approved therapies, and new clinical trial data, however, are changing best ...

  • Online Presentation Online Presentation
  • ACCME

The Importance of Continued Co-management in the Treatment of PsA: Examining the Crucial Coalition Between Dermatology and Rheumatology in Psoriatic Arthritis Treatment

Psoriatic arthritis (PsA) is a serious, inflammatory arthritis associated with psoriasis and multiple comorbidities that often requires collaborative care between dermatologists, rheumatologists, and primary care clinicians. This activity will examine specialty collaboration and guideline recommended treatment. ...

  • i-Newsletter i-Newsletter
  • ACCME

The Role of the Pharmacist in T2D: The Evolution of Insulin Therapy

This activity uses interactive case scenarios to examine the role of the pharmacist in the management of T2D. ...

  • Mobile + Online on RealCME
  • ACPE
Main Menu
EDITOR'S PICKS